Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
4.220
+1.420 (50.71%)
At close: Apr 3, 2025, 4:00 PM
4.390
+0.170 (4.03%)
Pre-market: Apr 4, 2025, 9:25 AM EDT
Alaunos Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Alaunos Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Alaunos Therapeutics.
Recommendation Trends
Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 0 |
Buy | 3 | 3 | 3 | 3 | 3 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 4 | 4 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 16, 2023 |
Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $225 | Hold → Strong Buy | Upgrades | $225 | +5,231.75% | May 15, 2023 |
Wells Fargo | Wells Fargo | Buy Initiates $450 | Buy | Initiates | $450 | +10,563.51% | Mar 27, 2023 |
Wells Fargo | Wells Fargo | Buy Initiates $450 | Buy | Initiates | $450 | +10,563.51% | Oct 4, 2022 |
Financial Forecast
Revenue This Year
568.06M
from 10.00K
Increased by 5,680,500.00%
Revenue Next Year
n/a
from 568.06M
EPS This Year
0.88
from -2.92
EPS Next Year
-0.14
from 0.88
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 584.8M | n/a |
Avg | 568.1M | n/a |
Low | 545.8M | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | 5,847,600.0% | - |
Avg | 5,680,500.0% | - |
Low | 5,457,800.0% | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | 0.90 | -0.15 |
Avg | 0.88 | -0.14 |
Low | 0.84 | -0.14 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.